세계의 공캡슐 시장 : 유형, 기능, 물리적 특성, 형태, 외관, 용도, 지역별 예측(-2032년)

Global Empty Capsule Market Research Report Information by Type (Gelatin Capsules [Porcine Gelatin and Bovine Gelatin {Skin Gelatin and Bone Gelatin} and Vegetarian Capsules [Hydroxypropyl Methylcellulose (HPMC) and Pullulan & Starch]), by Functionality (Fast-release Capsules and Slow-release Capsules), and by Physical Characteristics (Halal and Non-Halal), by Form (Hard Capsules and Soft Capsules), by Appearance (Transparent and Opaque) by Application (Pharmaceutical [Antibiotic & Antibacterial Drugs, Antacid & Antiflatulent, Anti-inflammatory drugs, and Others] and Nutraceutical), and by Region (North America, Europe, Asia-Pacific, and Rest of the World) Forecast till 2032

Market Overview

In 2023, the market size of empty capsules was estimated to be USD 31.83 billion. During the forecast period (2024-2032), the Empty Capsule Market industry is anticipated to experience a compound annual growth rate (CAGR) of 6.68%, increasing from USD 33.99 billion in 2024 to USD 60.78 billion by 2032. The global market is experiencing development due to the pharmaceutical industry's global expansion and advancements in capsule technology.

The global empty capsules market is experiencing significant growth, which is primarily driven by the increasing demand for nutraceuticals. The consumption of nutraceutical products has increased globally due to the growing interest in preventive healthcare and the pursuit of wellness. Empty capsules are frequently employed as the preferable encapsulation solution. The demand for empty capsules in the nutraceutical sector is primarily driven by their widespread use in the encapsulation of vitamins, minerals, and other nutritional supplements. Furthermore, empty capsules are essential in the nutraceutical industry, as they offer a convenient and efficient method for encapsulating a wide range of formulations.

Market segment insights

The global unfilled capsules market has been segmented into gelatin capsules and vegetarian capsules based on type.

The global empty capsules market has been divided into two categories: fast-release capsules and slow-release capsules, based on their functionality.

Halal and non-halal are the two categories into which the global empty capsules market has been divided on the basis of physical characteristics.

The global empty capsules market has been categorized into hard capsules and flexible capsules based on their form.

Transparent and opaque are the two categories into which the global empty capsules market has been divided.

The global empty capsules market has been divided into pharmaceutical and nutraceutical segments based on application.

Regional Perspectives

The market is segmented into four regions: North America, Europe, Asia-Pacific, and the Rest of the World. The pharmaceutical and nutraceutical industries were influenced by a variety of factors, which resulted in North America being the largest market in 2023. The market expansion can be attributed to the increasing demand for medication delivery solutions and the increasing prevalence of chronic diseases in the region. Additionally, the quality and efficacy of these pharmaceutical formulations have been improved by the implementation of new technologies and manufacturing processes in the production of empty capsules.

The Europe empty capsules market is undergoing substantial growth, which is being fueled by a growing geriatric population, rising consumer awareness of preventive healthcare, and an increase in pharmaceutical and nutraceutical activities. Lonza had expanded its Capsugel product line to include a white firm gelatin capsule that is free of titanium dioxide (TiO2). This expansion was in response to the growing demand from customers to satisfy the new titanium dioxide-free requirements for foods in the European Union. Empty capsules are in high demand, particularly in the pharmaceutical industry, due to their ability to conceal the flavor of active ingredients and deliver precise dosages.

In 2022, the Asia-Pacific Empty Capsules market was valued at USD 893.55 million and is anticipated to register a compound annual growth rate (CAGR) of 6.28% throughout the forecast period.

The Asia-Pacific empty capsules market is currently experiencing substantial growth and is expected to maintain its upward trajectory in the years ahead. Various factors, including the growing demand for unused capsules in the pharmaceutical and nutraceutical industries, are driving the market.

Major Players

Lonza (Switzerland), CapsCanada (Canada), Roxlor (US), Goerlich Pharma GmbH (Germany), Hunan Er-Kang Pharmaceutical Ltd. (China), Shanxi Guangsheng Medicinal Capsule Co., Ltd (China), Bright Pharma Caps Inc (US), ACG (India), Sunil Healthcare Limited (India), and Qualicaps (Japan) are among the key companies in the Empty Capsule Market.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

• 1.1 OVERVIEW

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 MARKET STRUCTURE
• 2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

• 3.1 DATA MINING
• 3.2 SECONDARY RESEARCH
• 3.3 PRIMARY RESEARCH
• 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
• 3.5 FORECASTING TECHNIQUES
• 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
  • 3.6.1 BOTTOM-UP APPROACH
  • 3.6.2 TOP-DOWN APPROACH
• 3.7 DATA TRIANGULATION
• 3.8 VALIDATION

4 MARKET DYNAMICS

• 4.1 OVERVIEW
• 4.2 DRIVERS
  • 4.2.1 GROWTH IN THE PHARMACEUTICAL INDUSTRY WORLDWIDE
  • 4.2.2 GROWING DEMAND FOR NUTRACEUTICALS
  • 4.2.3 ADVANCEMENTS IN CAPSULE TECHNOLOGY
• 4.3 RESTRAINTS
  • 4.3.1 DIETARY RESTRICTIONS AND CULTURAL PRACTICES TO HAMPER THE MARKET GROWTH
• 4.4 OPPORTUNITY
  • 4.4.1 GROWING PREFERENCES TOWARDS PLANT BASED CAPSULES

5 MARKET FACTOR ANALYSIS

• 5.1 VALUE CHAIN ANALYSIS
  • 5.1.1 R&D AND DESIGNING
  • 5.1.2 MANUFACTURING
  • 5.1.3 DISTRIBUTION AND SALES
  • 5.1.4 POST-SALES MONITORING
• 5.2 PORTER'S FIVE FORCES MODEL
  • 5.2.1 THREAT OF NEW ENTRANTS
  • 5.2.2 BARGAINING POWER OF SUPPLIERS
  • 5.2.3 THREAT OF SUBSTITUTES
  • 5.2.4 BARGAINING POWER OF BUYERS
  • 5.2.5 INTENSITY OF RIVALRY
• 5.3 IMPACT OF COVID-19 ON THE GLOBAL EMPTY CAPSULES MARKET
  • 5.3.1 IMPACT ON RESEARCH AND DEVELOPMENT
  • 5.3.2 IMPACT ON SUPPLY CHAIN
  • 5.3.3 IMPACT ON PRICING
• 5.4 CONSUMER TRENDS
• 5.5 RUSSIA-UKRAINE WAR IMPACT
• 5.6 REGULATORY LANDSCAPE BY REGION

6 GLOBAL EMPTY CAPSULES MARKET, BY TYPE

• 6.1 OVERVIEW
• 6.2 GELATIN CAPSULES
  • 6.2.1 PORCINE GELATIN
  • 6.2.2 BOVINE GELATIN
    • 6.2.2.1 SKIN GELATIN
    • 6.2.2.2 BONE GELATIN
• 6.3 VEGETARIAN CAPSULES
  • 6.3.1 HYDROXYPROPYL METHYLCELLULOSE (HPMC)
  • 6.3.2 PULLULAN & STARCH

7 GLOBAL EMPTY CAPSULES MARKET, BY FUNCTIONALITY

• 7.1 OVERVIEW
• 7.2 FAST-RELEASE CAPSULES
• 7.3 SLOW-RELEASE CAPSULES

8 GLOBAL EMPTY CAPSULES MARKET, BY PHYSICAL CHARACTERISTICS

• 8.1 OVERVIEW
• 8.2 HALAL
• 8.3 NON-HALAL

9 GLOBAL EMPTY CAPSULES MARKET, BY FORM

• 9.1 OVERVIEW
• 9.2 HARD CAPSULES
• 9.3 SOFT CAPSULES

10 GLOBAL EMPTY CAPSULES MARKET, BY APPEARANCE

• 10.1 OVERVIEW
• 10.2 TRANSPARENT
• 10.3 OPAQUE

11 GLOBAL EMPTY CAPSULES MARKET, BY APPLICATION

• 11.1 OVERVIEW
• 11.2 PHARMACEUTICAL
  • 11.2.1 ANTIBIOTIC & ANTIBACTERIAL DRUGS
  • 11.2.2 ANTACID & ANTIFLATULENT
  • 11.2.3 ANTI-INFLAMMATORY DRUGS
  • 11.2.4 OTHERS
• 11.3 NUTRACEUTICAL

12 GLOBAL EMPTY CAPSULES MARKET, BY REGION

• 12.1 OVERVIEW
• 12.2 NORTH AMERICA
  • 12.2.1 US
  • 12.2.2 CANADA
• 12.3 EUROPE
  • 12.3.1 GERMANY
  • 12.3.2 FRANCE
  • 12.3.3 UK
  • 12.3.4 ITALY
  • 12.3.5 SPAIN
  • 12.3.6 REST OF EUROPE
• 12.4 ASIA-PACIFIC
  • 12.4.1 CHINA
  • 12.4.2 INDIA
  • 12.4.3 JAPAN
  • 12.4.4 AUSTRALIA
  • 12.4.5 SOUTH KOREA
  • 12.4.6 REST OF ASIA-PACIFIC
• 12.5 REST OF THE WORLD
  • 12.5.1 MIDDLE EAST
  • 12.5.2 AFRICA
  • 12.5.3 LATIN AMERICA

13 COMPETITIVE LANDSCAPE

• 13.1 OVERVIEW
• 13.2 COMPETITIVE BENCHMARKING
• 13.3 LEADING PLAYERS IN TERMS OF PRODUCTION BY MAJOR REGION
  • 13.3.1 TOP GELATIN CAPSULE PRODUCERS BY REGION
• 13.4 MAJOR GROWTH STRATEGY IN THE GLOBAL EMPTY CAPSULE MARKET
• 13.5 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE EMPTY CAPSULE MARKET
• 13.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
  • 13.6.1 EXPANSION

14 COMPANY PROFILE

• 14.1 HUNAN ER-KANG PHARMACEUTICAL CO. LTD.
  • 14.1.1 COMPANY OVERVIEW
  • 14.1.2 FINANCIAL OVERVIEW
  • 14.1.3 SERVICES OFFERED
  • 14.1.4 KEY DEVELOPMENTS
  • 14.1.5 KEY STRATEGIES
• 14.2 SHANXI GUANGSHENG MEDICINAL CAPSULE CO., LTD.
  • 14.2.1 COMPANY OVERVIEW
  • 14.2.2 FINANCIAL OVERVIEW
  • 14.2.3 SERVICES OFFERED
  • 14.2.4 KEY DEVELOPMENTS
  • 14.2.5 SWOT ANALYSIS
  • 14.2.6 KEY STRATEGIES
• 14.3 BRIGHT PHARMA CAPS INC.
  • 14.3.1 COMPANY OVERVIEW
  • 14.3.2 FINANCIAL OVERVIEW
  • 14.3.3 SERVICE OFFERED
  • 14.3.4 KEY DEVELOPMENTS
  • 14.3.5 KEY STRATEGIES
• 14.4 ACG
  • 14.4.1 COMPANY OVERVIEW
  • 14.4.2 FINANCIAL OVERVIEW
  • 14.4.3 PRODUCTS OFFERED
  • 14.4.4 KEY DEVELOPMENTS
  • 14.4.5 FINANCIAL OVERVIEW
  • 14.4.6 KEY STRATEGIES
• 14.5 QUALICAPS
  • 14.5.1 COMPANY OVERVIEW
  • 14.5.2 FINANCIAL OVERVIEW
  • 14.5.3 PRODUCTS OFFERED
  • 14.5.4 KEY DEVELOPMENTS
  • 14.5.5 KEY STRATEGIES
• 14.6 SUNIL HEALTHCARE LIMITED
  • 14.6.1 COMPANY OVERVIEWS
  • 14.6.2 FINANCIAL OVERVIEW
  • 14.6.3 PRODUCTS OFFERED
  • 14.6.4 KEY DEVELOPMENTS
  • 14.6.5 KEY STRATEGIES
• 14.7 CAPSCANADA
  • 14.7.1 COMPANY OVERVIEW
  • 14.7.2 FINANCIAL OVERVIEW
  • 14.7.3 PROUCTS OFFERED
  • 14.7.4 KEY DEVELOPMENTS
  • 14.7.5 SWOT ANALYSIS
  • 14.7.6 KEY STRATEGIES
• 14.8 ROXLOR
  • 14.8.1 COMPANY OVERVIEW
  • 14.8.2 FINANCIAL OVERVIEW
  • 14.8.3 PRODUTCS OFFERED
  • 14.8.4 KEY DEVELOPMENTS
  • 14.8.5 KEY STRATEGIES
• 14.9 GOERLICH PHARMA GMBH
  • 14.9.1 COMPANY OVERVIEW
  • 14.9.2 FINANCIAL OVERVIEW
  • 14.9.3 PRODUCTS OFFERED
  • 14.9.4 KEY DEVELOPMENTS
  • 14.9.5 SWOT ANALYSIS
  • 14.9.6 KEY STRATEGIES
• 14.10 LONZA
  • 14.10.1 COMPANY OVERVIEW
  • 14.10.2 FINANCIAL OVERVIEW
  • 14.10.3 PRODUCTS OFFERED
  • 14.10.4 KEY DEVELOPMENTS
  • 14.10.5 SWOT ANALYSIS
  • 14.10.6 KEY STRATEGIES

15 APPENDIX

• 15.1 REFERENCES
• 15.2 RELATED REPORTS